Corcept Therapeutics
CORT
CORT
56 hedge funds and large institutions have $62.8M invested in Corcept Therapeutics in 2013 Q2 according to their latest regulatory filings, with 56 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Holders
56
Holders Change
+56
Holders Change %
–
% of All Funds
1.83%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
56
Increased
–
Reduced
–
Closed
–
Calls
$75K
Puts
$172K
Net Calls
-$97K
Net Calls Change
-$97K
Top Buyers
| 1 |
1
Federated Hermes
Pittsburgh,
Pennsylvania
|
$20.5M |
| 2 |
ISL
2
Ingalls & Snyder LLC
New York
|
$9.07M |
| 3 |
IA
3
Investor AB
Stockholm,
Sweden
|
$5.98M |
| 4 |
4
First Eagle Investment Management
New York
|
$4.39M |
| 5 |
5
Jennison Associates
New York
|
$3.7M |
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
51
Bank of America
Charlotte,
North Carolina
| $5K | 2,967 | +2,967 | New |
|
|
BG
52
BlackRock Group
London,
United Kingdom
| $4K | 2,397 | +2,397 | New |
|
|
TRCT
53
Tower Research Capital (TRC)
New York
| $3K | 2,000 | +2,000 | New |
|
54
BlackRock
New York
| $1K | 805 | +805 | New |
|
55
Group One Trading
Chicago,
Illinois
| – | – | – | – |
|
56
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | – | – | – |
|
57
Citigroup
New York
| $0 | 70 | +70 | New |
|
|
RFC
58
Russell Frank Company
Seattle,
Washington
| $0 | 279 | +279 | New |
|